• Users Online: 345
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 4  |  Issue : 2  |  Page : 109-115

Clinical profile of patients with prosthetic valve thrombosis treated with fibrinolysis


Department of Cardiology, TNMC and BYL Nair Ch. Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Dr. Digvijay Deeliprao Nalawade
Department of Cardiology, TNMC and BYL Nair Ch. Hospital, 18-ICCU, Ground Floor, OPD Building, Nair Hospital, Mumbai Central, Mumbai - 400 008, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpcs.jpcs_29_18

Rights and Permissions

Objective: Prosthetic valve thrombosis (PVT) is a potentially life-threatening complication. Fibrinolytic therapy is the first line of treatment in the developing countries mainly due to financial constraints and limited surgical availability. We performed a retrospective, single-center study to evaluate the clinical profile of patients with PVT treated with fibrinolysis. Methods: Data of 21 consecutive patients admitted with PVT and treated with fibrinolysis during 1-year study period (January 2017–January 2018) were retrospectively analyzed in terms of clinical characteristics and outcomes. Results: Out of 21 patients with 21 PVT episodes, there were 13 females (62%) and 8 males (38%) with a mean age of 35.2 ± 12.2 years (age range: 18–57 years). Presenting complaint in all patients was dyspnea with majority (90.5%) presenting in the New York Heart Association (NYHA) Class III/IV. Subtherapeutic international normalized ratio (<2.5) was found in 19 (90.5%) patients. Nineteen (90.5%) PVT episodes occurred in mitral position alone and two (9.5%) in both mitral and aortic. All patients were thrombolyzed with streptokinase with complete clinical success in 16 (76.2%), partial clinical success in 2 (9.5%), and inhospital mortality in 3 (14.3%) patients. Complications occurred in three (14.3%) patients, including one (4.8%) major (embolic stroke) and two (9.5%) minor (per vaginal bleed). Conclusions: Left-sided PVT is more common in mitral position than aortic with subtherapeutic anticoagulation being the major risk factor. Fibrinolysis can be considered as an effective and acceptable alternative to surgery, even for patients presenting with NYHA Class III/IV, especially in developing countries or in centers with limited resources.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed249    
    Printed6    
    Emailed0    
    PDF Downloaded45    
    Comments [Add]    

Recommend this journal